-
May 29, 2026 iProgen Out-Licenses AntibodyInternalization Technologies to AOCeraTherapeutics for Antibody Oligo ConjugateApplication.May 29, 2026iProgen Biotech out-licensed its Antibody Internalization Technologies to AOCeraTherapeutics Inc. (www.AOCera.com), headquartered in San Diego, USA....
-
June 25, 2025 iProgen and UBC Out-License NovelDegrader Antibody ConjugateTechnology to 3C Therapeutics Inc.iProgen Biotech and the University of British Columbia (UBC) have jointly out-licensed their novel modular Degrader Antibody Conjugate...
-
September 3, 2024 iProgen has out-licensed its protein internalization technology to Lucy Biotech Ltd. for the delivery of Anti-Freeze ProteinsiProgen Biotech out-licensed its intracellular protein delivery technology for enhanced delivery of antifreeze proteins to Lucy Biotech Ltd.,...
-
July 1, 2023 iProgen and Korean Basic Science Institute (KBSI) launches ADC research collaboration to treat Osteoporosis using Antibody Drug Conjugate technologyKorean Basic Science Institute (KBSI) and iProgen Biotech Inc. enters research collaboration to explore the application of Antibody...
-
April 13, 2022 Pioneering research collaboration to treat Sarcopenia using Antibody Drug Conjugate technologyAsan Medical Center (AMC) and iProgen Biotech Inc., enters research collaboration to explore the application of Antibody Drug...
-
April 1, 2022 iProgen and UBC launches ADC research collaboration to develop novel antibody-PROTAC technologyNational Science and Engineering Research Council approves grant to support two-year novel antibody-PROTAC technology research and development. UBC...
-
November 1, 2021 iProgen and Biorchestra launches research collaboration to explore applications of Antibody Oligo Conjugates to treat diseases with unmet medical needsBiorchestra and iProgen have been approved for an International Research Grant application (Canada-Korea) to work on the research...
-
October 28, 2020 East-West academic-industry research collaboration to identify lung cancer biomarkersRIKEN Research Institute, KEIO Medical University, iPrime Therapeutics Co. Ltd., and iProgen Biotech enters joint research collaboration to...
-
April 7, 2019 Celltrion Partners with iProgen Biotech to develop a series of novel ADCsCelltrion signs a partnership deal with the Canada-based iProgen Biotech Inc. to bolster its pipeline for novel biotherapeutics....
